DMARDs and gout therapy in patients with chronic arthritis and end-stage renal disease: a descriptive guide

Key Points

• To provide guidance on treating gout in ESRD patients with chronic arthritis, focusing on individual needs.
• Descriptive analysis of treatment approaches for gout in ESRD patients
• Recommendations based on existing practices
• Emphasis on careful monitoring of treatment outcomes
• Individualized treatment protocols may improve outcomes in ESRD patients with chronic arthritis
• Strict monitoring is essential to avoid complications during gout therapy
• Consideration of patient-specific factors improves treatment effectiveness